NEWS HIGHLIGHTS
Published Studies Related to Horizant (Gabapentin)
Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following
Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized
Clinical Trial. [2015]
for treating residual sleeping disturbances... CONCLUSION: This study revealed that gabapentin is comparable to clonazepam for
The effect of a combination of gabapentin and donepezil in an experimental pain
model in healthy volunteers: Results of a randomized controlled trial. [2014]
This double-blind, placebo-controlled, 3-period cross-over, 4-treatment option,
incomplete block study (ClinicalTrials.gov number NCT01485185), with an adaptive
design for sample size re-estimation, was designed to evaluate gabapentin plus
donepezil in an established experimental model of electrical hyperalgesia...
Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: a
meta-analysis of randomized controlled trials. [2014]
gabapentin for management of PHN... CONCLUSION: This meta-analysis indicates that gabapentin is an effective and
Sleep parameters and health-related quality of life with bazedoxifene/conjugated
estrogens: a randomized trial. [2014]
and active-controlled phase 3 trial... CONCLUSIONS: Symptomatic postmenopausal women who are treated with BZA/CE for 1
The effects of gabapentin on methadone based addiction treatment: a randomized
controlled trial. [2013]
Gabapentin is a potentially useful drug in alleviating the hyperexcitatory
painful states in the control of opiate dependence in acute detoxification and
the stabilization phase. This study aim was to evaluate the effectiveness of
gabapentin adds-on methadone therapy on lowering the methadone... This drug leads to
relief of withdrawal symptoms and lower methadone consumption.
Clinical Trials Related to Horizant (Gabapentin)
Gabapentin for Smoking Cessation [Completed]
Gabapentin is an anti-epileptic agent that has shown preliminary evidence of efficacy for
improving symptoms of cocaine and alcohol withdrawal in pilot studies. Since the
neurobiology of alcohol, cocaine and nicotine withdrawal is similar, the preliminary
evidence of efficacy of gabapentin for symptoms of alcohol and cocaine withdrawal suggests,
that gabapentin might likely help nicotine withdrawal symptoms and thus tobacco abstinence.
The effect of gabapentin on two of the neurotransmitters, gamma-aminobutyric acid (GABA) and
glutamate further suggest a potential therapeutic mechanism for gabapentin in tobacco
abstinence. However, the exact mechanism of action of gabapentin is currently not known.
We have recently completed an open label pilot trial of gabapentin for tobacco abstinence
involving 50 smokers. The findings from that study provide promising preliminary results
and suggest that further testing of gabapentin for helping cigarette smokers quit tobacco
use is worth pursuing. Overall, gabapentin is well tolerated and has low abuse potential.
Our goal is to evaluate novel, safe, acceptable, and effective therapies that may help
increase tobacco abstinence rates. Currently, no randomized trials testing the efficacy of
gabapentin for smoking abstinence have been published. While our previous study provides
promising evidence regarding the potential efficacy of gabapentin for smoking abstinence, an
additional dose ranging study is needed prior to pursuing a large randomized trial. The
primary aim of the dose ranging study will be to obtain additional evidence of efficacy, and
information on the optimal dose of gabapentin to employ in the larger randomized controlled
trial.
Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting [Enrolling by invitation]
Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin [Recruiting]
The purpose of this study is to evaluate the patient experience when using gabapentin with
other pain control medications after posterior spinal fusion surgery for scoliosis in
adolescents. These results will be compared to patients who underwent the same procedure
during the study period and received the same standardized pain control regimen excluding
gabapentin. Effects on pain level, opioid use, satisfaction and narcotic use after discharge
from the hospital will be measured. Opioid side effects including nausea, sedation and
urinary retention (inability to empty one's bladder) will also be recorded. The null
hypotheses are as follows:
1. There is no significant difference in pain control when adding gabapentin to a
multimodal pain management protocol in pediatric post-operative posterior spinal fusion
patients.
2. There is no significant difference in the amount of opiate medication required for pain
control in pediatric post-operative posterior spinal fusion patients.
The Effects of Gabapentin Premedication on Neurosurgery [Recruiting]
The study is to observe the effects of gabapentin premedication on postoperative
pain,vomiting and nausea in patients undergoing neurosurgery. 100 neurosurgical patients are
randomized into groups gabapentin(GG) or placebo(GP). Patients are given gabapentin or
placebo orally the night before operation day and 2hours before surgery,respectively. The
investigators hypothesized that lower incidence of postoperative pain,vomiting and nausea
be observed in GG than GP.
The Effectiveness of Gabapentin for Post-operative Pain Following Cesarean Section [Completed]
Gabapentin has been very effective at treating pain after knee and hip operations,
hysterectomies, and many other types of operations. A previous study at the investigators'
hospital found that a single pre-operative dose of 600mg gabapentin produced a significant
reduction in pain after caesarean section. However, 19% complained of sedation. The purpose
of this study is to see whether a reduced dose of gabapentin will produce a similar
improvement in pain scores while avoiding adverse effects such as sedation or dizziness. The
objective of this study is to compare the efficacy of a single pre-operative oral dose of
gabapentin 300mg, versus 600mg and placebo in women undergoing Cesarean section. The
investigators' hypothesis is that gabapentin 300mg will result in decreased pain scores
similar to gabapentin 600mg, but with reduced side effects.
|
